Opiates act centrally on GH and PRL release

Area of Science:

• Neuroendocrinology
• Pharmacology

Background:

• Opiates are known to influence the release of hormones like growth hormone (GH) and prolactin.
• The precise location (central nervous system vs. periphery) where opiates exert these effects remains incompletely understood.

Purpose of the Study:

• To determine if the central nervous system or peripheral tissues mediate the effects of opiates on growth hormone and prolactin release.
• To investigate the role of the blood-brain barrier in opiate-induced hormonal changes.

Main Methods:

• Male rats were pretreated with saline, naloxone-HCl (an opiate antagonist that crosses the blood-brain barrier), or naloxone methyl bromide (Naloxone-Br, a quaternary derivative that does not cross the blood-brain barrier).
• Morphine hydrochloride (morphine-HCl) was administered, and subsequent release of prolactin and growth hormone was measured.
• Further experiments involved intraventricular and peripheral administration of morphine-methyl-iodide (morphine-I), a quaternary derivative that does not cross the blood-brain barrier.

Main Results:

• Morphine-HCl increased prolactin and growth hormone release when animals were pretreated with Naloxone-Br (peripheral antagonist), but not with naloxone-HCl (central antagonist).
• Naloxone-Br inhibited morphine's effect when administered directly into the brain ventricles.
• Peripheral administration of morphine-I did not affect hormone release, whereas intraventricular administration of morphine-I was effective.

Conclusions:

• The effects of opiates on growth hormone and prolactin release are primarily mediated by the central nervous system.
• The blood-brain barrier plays a critical role in determining the efficacy of opiate administration on these hormonal pathways.
• These findings highlight the central mechanisms underlying opiate-induced neuroendocrine responses.